Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Lentiviral modification combined with ex vivo erythroid differentiation was used to stably inhibit RhAG expression, a critical component of the Rh(rhesus) membrane complex defective in the Rh null syndrome. The cultured red cells generated recapitulate the major alterations of native Rh null cells regarding antigen expression, membrane deformability, and gas transport function, providing the proof of principle for their use as model of Rh null syndrome and to investigate Rh complex biogenesis in human primary erythroid cells. Using this model, we were able to reveal for the first time that RhAG extinction alone is sufficient to explain ICAM-4 and CD47 loss observed on native Rh null RBCs. Together with the effects of RhAG forced expression in Rh null progenitors, this strongly strengthens the hypothesis that RhAG is critical to Rh complex formation. The strategy is also promising for diagnosis purpose in order to overcome the supply from rare blood donors and is applicable to other erythroid defects and rare phenotypes, providing models to dissect membrane biogenesis of multicomplex proteins in erythroid cells, with potential clinical applications in transfusion medicine. Am. J. Hematol. 88:343-349, 2013. V C 2013 Wiley Periodicals, Inc. IntroductionLarge-scale approach to generate ex vivo mature erythroid cells sharing all functional characteristics with native adult RBCs [1] is well suited to investigate erythroidrestricted human disorders [2], particularly if coupled with lentiviral modification to modulate specific gene expression. The purpose of this study was to provide a proof of principle to reproduce a phenotype with functional alterations of RBC. Accordingly, we choose to mimic blood group Rhdeficiency (also called Rh null ), a rare autosomal recessive disorder affecting the RBC membrane in humans, which is associated with a hemolytic anemia of varying severity, abnormal red cell shape (stomato-spherocytosis), and osmotic fragility [3,4]. RBCs from Rh-deficient individuals basically lack Rh and LW blood group antigens, and Ss antigens expression is reduced [5]. Biochemical analysis have shown that these RBCs are severely deficient in the Rh complex, an oligomeric assembly of two erythroidspecific proteins, Rh (Rhesus), and RhAG (Rh-Associated Glycoprotein), to which accessory chains such as ICAM-4 (carrier of LW antigens), CD47 and glycophorin B (carrier of Ss antigens) are linked by noncovalent bonds. Molecular studies have revealed that Rh-deficiency is caused by different mutations that occur in either the RHAG or RH locus, but the genes encoding the accessory chains remain unaltered [3,4]. This is consistent with the inheritance of Rh null phenotypes by two distinct genetic backgrounds. The "amorph" type is caused by homozygosity for mutant alleles at the RH locus (1p34-36) and the "regulator" type by homozygosity (or composite heterozygosity) for mutants alleles at the genetically independent RHAG locus (6p12-21) encoding the RhAG protein subunit [6]. These findings suggest that when either the Rh...
Lentiviral modification combined with ex vivo erythroid differentiation was used to stably inhibit RhAG expression, a critical component of the Rh(rhesus) membrane complex defective in the Rh null syndrome. The cultured red cells generated recapitulate the major alterations of native Rh null cells regarding antigen expression, membrane deformability, and gas transport function, providing the proof of principle for their use as model of Rh null syndrome and to investigate Rh complex biogenesis in human primary erythroid cells. Using this model, we were able to reveal for the first time that RhAG extinction alone is sufficient to explain ICAM-4 and CD47 loss observed on native Rh null RBCs. Together with the effects of RhAG forced expression in Rh null progenitors, this strongly strengthens the hypothesis that RhAG is critical to Rh complex formation. The strategy is also promising for diagnosis purpose in order to overcome the supply from rare blood donors and is applicable to other erythroid defects and rare phenotypes, providing models to dissect membrane biogenesis of multicomplex proteins in erythroid cells, with potential clinical applications in transfusion medicine. Am. J. Hematol. 88:343-349, 2013. V C 2013 Wiley Periodicals, Inc. IntroductionLarge-scale approach to generate ex vivo mature erythroid cells sharing all functional characteristics with native adult RBCs [1] is well suited to investigate erythroidrestricted human disorders [2], particularly if coupled with lentiviral modification to modulate specific gene expression. The purpose of this study was to provide a proof of principle to reproduce a phenotype with functional alterations of RBC. Accordingly, we choose to mimic blood group Rhdeficiency (also called Rh null ), a rare autosomal recessive disorder affecting the RBC membrane in humans, which is associated with a hemolytic anemia of varying severity, abnormal red cell shape (stomato-spherocytosis), and osmotic fragility [3,4]. RBCs from Rh-deficient individuals basically lack Rh and LW blood group antigens, and Ss antigens expression is reduced [5]. Biochemical analysis have shown that these RBCs are severely deficient in the Rh complex, an oligomeric assembly of two erythroidspecific proteins, Rh (Rhesus), and RhAG (Rh-Associated Glycoprotein), to which accessory chains such as ICAM-4 (carrier of LW antigens), CD47 and glycophorin B (carrier of Ss antigens) are linked by noncovalent bonds. Molecular studies have revealed that Rh-deficiency is caused by different mutations that occur in either the RHAG or RH locus, but the genes encoding the accessory chains remain unaltered [3,4]. This is consistent with the inheritance of Rh null phenotypes by two distinct genetic backgrounds. The "amorph" type is caused by homozygosity for mutant alleles at the RH locus (1p34-36) and the "regulator" type by homozygosity (or composite heterozygosity) for mutants alleles at the genetically independent RHAG locus (6p12-21) encoding the RhAG protein subunit [6]. These findings suggest that when either the Rh...
The GYPC gene encodes the glycophorins C and D. The two moieties express 12 known antigens of the Gerbich blood group system and functionally stabilize red blood cell membranes through their intracellular interaction with protein 4.1 and p55. Three GYPC exon deletions are responsible for the lack of the high-frequency antigens Ge2 (Yus type, exon 2 deletion), Ge2 and Ge3 (Gerbich type, exon 3 deletion), and Ge2 to 4 (Leach type, exons 3 and 4 deletion), but lack exact molecular description. A total of 29 rare blood samples with Yus (GE:-2,3,4) and Gerbich (GE:-2,-3,4) phenotypes, including individuals of Middle-Eastern, North-African or Balkan ancestry were examined genetically. All phenotypes could be explained by 4 different Yus alleles, characterized by deletions of exon 2 and adjacent introns, and 3 different Gerbich alleles, with deletions of exon 3 and adjacent introns. A 3600 base pair GYPC region, encompassing exon 2 and flanking region, shares a high degree of sequence homology with a region flanking exon 3, probably representing an evolutionary duplication event. Defining the expression of Gerbich variants presently relies on rare serological reagents. Our approach substitutes the serological characterization with a precise genotype approach to identify the rare Yus and Gerbich alleles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.